// App-Quantinova.ai

: Level of Power Increase on Admission Determines Successful Treatment with Enhanced Anticoagulation with HeartWare Ventricular Assist Device Thrombosis

Researchers

Presenter

  • A. Woods

Principal Investigators

  • S. Schueler

  • S. Tovey

  • N. Robinson Smith

  • J. Jungshleger

  • G. MacGowan

Medical Centers

  • Cardiothoracic, Newcastle upon Tyne NHS Foundations Trust, Newcastle upon Tyne, United Kingdom

  • Freeman Hospital, Newcastle upon Tyne, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Cardiovascular (CVS)

  • Blood/haematological Diseases

  • Pulmonary/Respiratory Diseases

Disease

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • Bivalirudin

  • Activase I.V.

  • Warfarin

  • Aspirin

  • Albyl-E

  • Heparin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved